Candida kefyr - Open Access .click

Results 141 to 150 of about 2,158 (156)

Some of the next articles are maybe not open access.

???????????????? ???? ???????????????????????????? ?????????????????????????????????????? ???????????????? Candida kefyr

2017
???????????????? ???????????????? ?????????????????????????????????????????? ?????????????? ?????????????? ?????????? 162 ??????????????, ?????????????????????????? ???? ?????????????????? ????????????????, ?? 28 ??????????????, ?????????????????????????? ???? ????????. ???????????? ???????????? ?????????????? ???????????????????? ?????????????? ?? ????
openaire +1 more source

Emerging Pathogen: Candida kefyr (Kluvyeromyces marxianus)

2017
In the central microbiology laboratory of Gazi University Hospital Candida kefyr was isolated from different clinical samples as 5.3% in 2016 and in 2017 this rate increased to 9.3% which was nearly twofold and this has drawn our attention. The aim of this study was to evaluate the special characteristics, antifungal susceptibility and virulence ...
Cuhadar, Tugba, KALKANCI, AYŞE
openaire +1 more source

Decreased Killing Activity of Micafungin Against Candida guilliermondii, Candida lusitaniae, and Candida kefyr in the Presence of Human Serum.

Microbial drug resistance (Larchmont, N.Y.), 2018
Currently, echinocandins are first-line drugs for treatment of invasive candidiasis. However, data on how serum influences killing activity of echinocandins against uncommon Candida species are limited. Therefore, the killing activity of micafungin in RPMI-1640 and in 50% serum was compared against Candida guilliermondii, Candida lusitaniae, and ...
Qasem, Saleh +6 more
openaire +1 more source

P1289 Candida kefyr: a new emerging pathogen?